» Articles » PMID: 9422424

Blockade of the CD40-CD40 Ligand Pathway Potentiates the Capacity of Donor-derived Dendritic Cell Progenitors to Induce Long-term Cardiac Allograft Survival

Overview
Journal Transplantation
Specialty General Surgery
Date 1998 Jan 9
PMID 9422424
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Failure of costimulatory molecule-deficient donor dendritic cells (DCs) to induce indefinite allograft acceptance may be a result of the 'late" up-regulation of these molecules on the DCs after interaction with host T cells. Ligation of CD40 on antigen-presenting cells by its cognate ligand CD40L is thought to induce expression of CD80 (B7-1) and CD86 (B7-2). We examined the influence of anti-CD40L monoclonal antibody (mAb) on the capacity of donor-derived DC progenitors to induce long-term allograft survival.

Methods: High purity DC progenitors were grown from B10 (H2b) mouse bone marrow in granulocyte-macrophage colony-stimulating factor and transforming growth factor beta1 (TGFbeta1). Mature DC were propagated in granulocyte-macrophage colony-stimulating factor and interleukin-4. Their phenotype was characterized by flow cytometric analysis and their function by mixed leukocyte reactivity. Anti-donor cytotoxic T lymphocyte activity in grafts and spleens of vascularized heart allograft recipients was also assessed.

Results: The TGFbeta3-cultured cells were (1) DEC 205-positive, MHC class II-positive, CD80dim, CD86dim, and CD40dim, (2) poor stimulators of naive allogeneic T-cell proliferation, and (3) able to prolong significantly B10 cardiac allograft survival in C3H (H2k) recipients when given (2 x 10[6] i.v.) 7 days before organ transplantation (median survival time [MST] 26 days vs. 12 days in controls, and 5 days in interleukin-4 DC-treated animals). Their allostimulatory activity was further diminished by addition of anti-CD40L mAb at the start of the mixed leukocyte cultures. Anti-CD40L mAb alone (250 microg/mouse, i.p.; day -7) did not prolong cardiac graft survival (MST 12 days). In contrast, TGFbeta-cultured DCs + anti-CD40L mAb extended graft survival to a MST of 77 days, and inhibited substantially the anti-donor cytotoxic T lymphocyte activity of graft-infiltrating cells and host spleen cells assessed 8 days after transplant.

Conclusions: The CD40-CD40L pathway appears important in regulation of allogeneic DC-T-cell functional interaction in vivo; its blockade increases markedly the potential of costimulatory molecule-deficient DCs of donor origin to induce long-lasting allograft survival.

Citing Articles

Innate immune cellular therapeutics in transplantation.

Ott L, Cuenca A Front Transplant. 2023; 2.

PMID: 37994308 PMC: 10664839. DOI: 10.3389/frtra.2023.1067512.


Regulatory Macrophages and Tolerogenic Dendritic Cells in Myeloid Regulatory Cell-Based Therapies.

Suuring M, Moreau A Int J Mol Sci. 2021; 22(15).

PMID: 34360736 PMC: 8348814. DOI: 10.3390/ijms22157970.


LPS enhances CTB-INSULIN induction of IDO1 and IL-10 synthesis in human dendritic cells.

Kim N, Torrez T, Langridge W Cell Immunol. 2019; 338:32-42.

PMID: 30910218 PMC: 6481636. DOI: 10.1016/j.cellimm.2019.03.003.


Upregulation of Heme Oxygenase-1 Endues Immature Dendritic Cells With More Potent and Durable Immunoregulatory Properties and Promotes Engraftment in a Stringent Mouse Cardiac Allotransplant Model.

Zhao Y, Jia Y, Wang L, Chen S, Huang X, Xu B Front Immunol. 2018; 9:1515.

PMID: 30013566 PMC: 6036127. DOI: 10.3389/fimmu.2018.01515.


Update on Dendritic Cell-Induced Immunological and Clinical Tolerance.

Obregon C, Kumar R, Pascual M, Vassalli G, Golshayan D Front Immunol. 2017; 8:1514.

PMID: 29250057 PMC: 5715373. DOI: 10.3389/fimmu.2017.01514.